Combined corticosteroid and long‐acting beta2‐agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, August 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

wikipedia: 3 Wikipedia pages

Citations

dimensions_citation: 121 Dimensions

Readers on

mendeley: 265 Mendeley
citeulike: 1 CiteULike

Summary Policy documents Wikipedia Dimensions citations

So far, Dimensions has found 121 publications that cite this research output.

121

The most recent citing publications are shown below. View all 121 publications that cite this research output on Dimensions.

Current pharmacotherapy of COPD

Book chapter (March 2024)

Network meta-analysis of the efficacy and safety of monoclonal antibodies and traditional conventional dichotomous agents for chronic obstructive pulmonary disease

Article in Frontiers in Medicine (February 2024)

Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B2-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study

Article in BMJ Open (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.